Skip to main content
. 2019 Jun 16;11(6):403–412. doi: 10.4253/wjge.v11.i6.403

Table 4.

Post-procedure outcomes

Factor Non-cirrhotics Cirrhotics Statistics P value
Clinical success 23 (92.0) 3 (60.0) -32.0 (-75.2, 18.3) 0.12d
Successful stent removal following resolution 20 (80.0) 3 (60.0) -20.0 (-71.6, 29.9) 0.57d
Total number of endoscopic procedures prior to removal 1.5 ± 0.94 2.0 ± 1.7 0.55 (-0.80, 1.9) 0.41a
ERCP performed within 30 d post drainage 5 (20.0) 1 (20.0) 0.00 (-52.2, 52.2) 0.99d
Recurrence of PFC needing reintervention 4 (16.0) 0 (0.0) -16.0 (-60.1, 37.5) 0.99d
Need for surgery 2 (8.0) 0 (0.0) -8.0 (-56.2, 41.3) 0.99d
Any adverse events 7 (28.0) 3 (60.0) 12.0 (-37.5, 60.1) 0.62d
Bleeding 1 (4.0) 1 (20.0) 16.0 (-33.8, 64.4) 0.31d
Infection 5 (20.0) 2 (40.0) 20.0 (-29.9, 71.6) 0.57d
Stent migration 1 (4.0) 0 (0.0) -4.0 (-52.4, 45.0) 0.99d
Any severe AE 2 (8.0) 0 (0.0) -8.0 (-56.2, 41.3) 0.99d
Any fatal AE 0 (0.0) 2 (40.0) 40.0 (-10.3, 85.3) 0.023d
Any severe/fatal AE 2 (8.0) 2 (40.0) 32.0 (-18.3, 75.2) 0.12d
Length of post-procedure hospitalization (d) 5.6 ± 13.7 18.6 ± 20.3 13.0 (-1.9, 27.9) 0.084a
Follow-up (mo) 14.1 ± 9.5 5.5 ± 5.1 -8.6 (-17.6, 0.49) 0.063a

Statistics presented as mean ± SD or n (%). P values:

a

ANOVA; bFisher’s exact test. AE: Adverse event; ERCP: Endoscopic retrograde cholangiopancreatography; PFC: Pancreatic fluid collection.